Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes.
Melissa R RiesterAndrew R ZulloRicha JoshiLori A DaielloKaleen N HayesDarae KoDae Hyun KimSebastian SchneeweissSarah D BerryPublished in: Diabetes, obesity & metabolism (2024)
SGLT2is do not have superior, and may have inferior, effectiveness compared with GLP-1RAs for cardiovascular and mortality outcomes in NH residents. Residents initiating SGLT2is should be monitored closely for DKA.